Healthcare


 Compumedics Secures $20M in Chinese MEG Sales as Demand for Brain Imaging Tech Rises

Compumedics Secures $20M in Chinese MEG Sales as Demand for Brain Im...

March 21, 2025 06:57 PM AEDT | By Team Kalkine Media

Highlights,$20M in MEG system sales achieved in China,Latest $5.7M deal signed with Hangzhou Normal University,Growing momentum signals strong future...

 Nanosonics Shares Surge After US Approval, But Analysts Urge Caution on Valuation

Nanosonics Shares Surge After US Approval, But Analysts Urge Caution...

March 21, 2025 04:42 PM AEDT | By Team Kalkine Media

Highlights,Nanosonics shares jump after US FDA greenlight,CORIS tool sees early investor excitement,Analysts flag slow rollout and valuation concerns,...

 Can Cochlear (ASX:COH) Regain Momentum in 2025? Here’s What the Numbers Say

Can Cochlear (ASX:COH) Regain Momentum in 2025? Here’s What the Numb...

March 21, 2025 02:42 PM AEDT | By Team Kalkine Media

Highlights,Revenue growth averaging 14.3% per year over 3 years,Strong gross margin of 74.9% and healthy net profit,Low debt levels and solid return o...

 MedAdvisor Limited's (ASX:MDR) Stock Performance: A Deep Dive

MedAdvisor Limited's (ASX:MDR) Stock Performance: A Deep Dive

March 21, 2025 01:30 PM AEDT | By Team Kalkine Media

Highlights,MedAdvisor Limited (ASX:MDR) has seen a significant stock price drop.,The company’s growth forecasts are lagging behind the industry.,Reven...

 ResMed (ASX:RMD) A Closer Look at Its Market Performance and Growth Potential

ResMed (ASX:RMD) A Closer Look at Its Market Performance and Growth...

March 21, 2025 12:07 PM AEDT | By Team Kalkine Media

Highlights,ResMed’s Market Movement,: Shares of ResMed (RMD) have declined by 4.6% since the start of 2025.,Healthcare Industry Resilience,: The secto...

 FDA Greenlights Telix’s Advanced Prostate Cancer Imaging Agent, Gozellix®

FDA Greenlights Telix’s Advanced Prostate Cancer Imaging Agent, Goze...

March 21, 2025 12:05 PM AEDT | By Team Kalkine Media

Highlights,FDA approves,Telix’s,next-gen prostate cancer imaging agent,Gozellix,® offers wider access through extended shelf life,Reimbursement eligib...

 Reviving Potential: How Race Oncology’s Breakthrough Could Redefine Cancer Treatment

Reviving Potential: How Race Oncology’s Breakthrough Could Redefine...

March 21, 2025 11:37 AM AEDT | By Team Kalkine Media

Highlights,Race Oncology brings back a shelved cancer drug with modern innovation,New formulation offers 20 years of exclusive patent protection,Poten...

 Anteris Technologies' DurAVR® Transcatheter Valve Shows Strong One-Year Performance, Paving the Way for Next Steps

Anteris Technologies' DurAVR® Transcatheter Valve Shows Strong One-Y...

March 21, 2025 11:29 AM AEDT | By Team Kalkine Media

Highlights,DurAVR,® THV continues to,demonstrate,exceptional durability and hemodynamic performance.,No cases of prosthesis-patient mismatch (PPM) wer...

 Understanding the Dynamics Behind Immutep Limited's (ASX:IMM) Shareholding

Understanding the Dynamics Behind Immutep Limited's (ASX:IMM) Shareh...

March 20, 2025 01:32 PM AEDT | By Team Kalkine Media

Highlights,Institutional investors hold the majority shares in Immutep Limited (IMM).,The top seven investors control over 50% of the company's stock....

 Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

March 20, 2025 01:31 PM AEDT | By Team Kalkine Media

Highlights,Red Metal shows a 14-month cash runway as of December 2024.,Cash burn reduced by 6% year over year.,Future cash raises may lead to sharehol...

 Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Commercial Sales of geneType Products

Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Comme...

March 20, 2025 12:56 PM AEDT | By Team Kalkine Media

Highlights,First commercial sales recorded for,geneType,products.,Strategic growth targeted in enterprise and global markets.,Anticipation builds for...

 Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low Price-to-Sales Ratio

Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low...

March 20, 2025 12:52 PM AEDT | By Team Kalkine Media

Highlights,Doctor Care Anywhere Group sports a notably low P/S ratio.,Recent revenue trends fall short compared to industry growth.,Future revenue pro...

 Optimism in the Australian Healthcare Sector: Analysts Highlight CSL and ResMed

Optimism in the Australian Healthcare Sector: Analysts Highlight CSL...

March 20, 2025 11:43 AM AEDT | By Team Kalkine Media

Highlights,Positive outlook for CSL (CSL) and ResMed (RMD).,Balanced prospects for other healthcare stocks.,Caution,advised,for Ramsay Health Care and...

 We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate

We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn...

March 19, 2025 03:34 PM AEDT | By Team Kalkine Media

Highlights:,LTR Pharma maintains a strong cash position with no outstanding debt.,Recent cash burn increase attributed to operational expansion.,Futur...

 Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Raising Announcement

Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Ra...

March 19, 2025 11:40 AM AEDT | By Team Kalkine Media

Highlights,Imricor,(IMR) shares suspended ahead of capital raising announcement.,Trading halt in effect until company provides details.,Imricor,plans...

 Emvision's Remote Stroke Detection Breakthrough and Biotech Sector Developments

Emvision's Remote Stroke Detection Breakthrough and Biotech Sector D...

March 19, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,Emvision Medical Devices (EMV) initiates trial for innovative remote stroke detection technology.,Despite challenging market conditions, se...

 Syntara (ASX:SNT) shareholders have experienced remarkable returns, over the past year.

Syntara (ASX:SNT) shareholders have experienced remarkable returns,...

March 19, 2025 09:33 AM AEDT | By Team Kalkine Media

Highlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareho...

 Pro Medicus Limited (ASX:PME) have recently been purchasing more shares.

Pro Medicus Limited (ASX:PME) have recently been purchasing more sha...

March 19, 2025 09:32 AM AEDT | By Team Kalkine Media

Highlights,Insiders hold 49% of ASX:PME shares, indicating significant vested interests.,Top 4 shareholders control 51% of the company, influencing ke...

 Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval for Striate+

Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval...

March 18, 2025 05:08 PM AEDT | By Team Kalkine Media

Highlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion effor...

 CLEO Diagnostics initiates the transfer of intellectual property for ovarian cancer blood tests to manufacturers in the US.

CLEO Diagnostics initiates the transfer of intellectual property for...

March 18, 2025 03:31 PM AEDT | By Team Kalkine Media

Highlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibo...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.